CNCEC(SH:601117)2023-04-28 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥42,590,794,292.02, representing a year-on-year increase of 20.68%[3] - The net profit attributable to shareholders for Q1 2023 was ¥1,110,931,540.85, reflecting a growth of 13.69% compared to the same period last year[3] - The company experienced a 12.5% increase in basic earnings per share, reaching ¥0.18 for Q1 2023[3] - The net profit attributable to the parent company for Q1 2023 was 1.111 billion RMB, reflecting a year-on-year growth of 13.72%[10] - Net profit for Q1 2023 was RMB 1.16 billion, up 7.6% from RMB 1.08 billion in Q1 2022[15] - The total comprehensive income for Q1 2023 was a loss of ¥29,941,160.47, contrasting sharply with a comprehensive income of ¥1,473,824,534.87 in Q1 2022[22] Cash Flow - The net cash flow from operating activities was negative at ¥6,020,685,337.45, indicating a significant cash outflow[3] - Cash flow from operating activities showed a net outflow of RMB 6.02 billion, an improvement from a net outflow of RMB 6.88 billion in Q1 2022[16] - The cash inflow from operating activities in Q1 2023 was ¥735,060,251.41, compared to ¥279,249,199.03 in Q1 2022, showing improved operational efficiency[24] - The company reported a net cash outflow from investing activities of ¥799,000,000.00 in Q1 2023, compared to an outflow of ¥1,550,313,537.84 in Q1 2022[23] - The company reported a net cash outflow of approximately $4.68 billion for the quarter, an improvement from $8.08 billion in the same quarter last year[17] Assets and Liabilities - Total assets at the end of Q1 2023 amounted to ¥199,443,149,821.66, which is a 2.51% increase from the end of the previous year[4] - The total liabilities increased to 139.839 billion RMB from 136.240 billion RMB at the end of 2022[13] - Total assets amounted to approximately $42.93 billion, slightly up from $42.84 billion at the end of the previous year[19] - Total liabilities increased to approximately $4.33 billion, compared to $4.20 billion at the end of the previous year, reflecting a rise of 2.5%[19] Equity - The company's equity attributable to shareholders increased to ¥54,044,618,662.18, up by 2.18% from the previous year-end[4] - The equity attributable to shareholders of the parent company was 54.045 billion RMB, compared to 52.890 billion RMB at the end of 2022[13] - The total equity of the company stood at approximately $38.60 billion, down from $38.63 billion at the end of the previous year[20] Research and Development - Research and development expenses surged by 68.53%, highlighting the company's commitment to enhancing its technological capabilities[6] - Research and development expenses increased significantly to RMB 1.01 billion, a 68.6% rise compared to RMB 596.97 million in Q1 2022[14] - The company’s research and development expenses for Q1 2023 were ¥33,360,000.00, reflecting ongoing investment in innovation[21] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 100,362, with the largest shareholder holding 35.72% of the shares[8] Contracts and Revenue Sources - The new contract amount signed during the reporting period was 104.597 billion RMB, up 0.66% compared to the same period last year[10] - Domestic contracts accounted for 97.966 billion RMB, while overseas contracts totaled 6.631 billion RMB[10]